Pharmaceuticals (289) | Note Agreements (289)
Browse by Company
-
Acer Therapeutics Inc. (1)
-
ACURA PHARMACEUTICALS, INC (8)
-
Adamis Pharmaceuticals Corp (3)
-
ALIMERA SCIENCES INC (1)
-
AmeriCann, Inc. (2)
-
Applied BioSciences Corp. (3)
-
APRICUS BIOSCIENCES, INC. (1)
-
Aquestive Therapeutics, Inc. (2)
-
Assertio Therapeutics, Inc (3)
-
Baudax Bio, Inc. (1)
-
Bespoke Extracts, Inc. (1)
-
BioPharmX Corp (1)
-
BODY & MIND INC. (1)
-
Boston Therapeutics, Inc. (2)
-
Canbiola, Inc. (10)
-
Cannabics Pharmaceuticals Inc. (3)
-
CANNAPHARMARX, INC. (1)
-
CARDAX, INC. (6)
-
Celexus, Inc (4)
-
Cerecor Inc. (2)
-
CLS Holdings USA, Inc. (2)
-
ContraVir Pharmaceuticals, Inc. (1)
-
Cure Pharmaceutical Holding Corp. (8)
-
Endexx Corp (2)
-
Eton Pharmaceuticals, Inc. (2)
-
Evofem Biosciences, Inc. (2)
-
Evolus, Inc. (3)
-
Exactus, Inc. (2)
-
GB SCIENCES INC (13)
-
GREEN HYGIENICS HOLDINGS INC. (5)
-
Green Thumb Industries Inc. (2)
-
IMAGING3 INC (17)
-
INNOVATE BIOPHARMACEUTICALS, INC. (5)
-
IntelGenx Technologies Corp. (2)
-
Intersect ENT, Inc. (1)
-
Jaguar Health, Inc. (7)
-
Johnson & Johnson (1)
-
Kannalife Inc (3)
-
KEMPHARM, INC (4)
-
Level Brands, Inc. (1)
-
Lilly (Eli) & Co. (8)
-
Mallinckrodt (1)
-
Medicine Man Technologies, Inc. (3)
-
MedMen Enterprises, Inc. (1)
-
Merck (10)
-
MICROCHANNEL TECHNOLOGIES CORP (16)
-
MJ Holdings, Inc. (6)
-
MYnd Analytics, Inc. (5)
-
Neos Therapeutics, Inc. (4)
-
NewBridge Global Ventures, Inc. (4)
-
NEXIEN BIOPHARMA, INC. (2)
-
Notis Global, Inc. (4)
-
NovaBay Pharmaceuticals, Inc. (5)
-
Novan, Inc. (1)
-
OCULAR THERAPEUTIX, INC (1)
-
OPIANT PHARMACEUTICALS, INC. (1)
-
OptiNose, Inc. (1)
-
Panacea Acquisition Corp (3)
-
Pharmagreen Biotech Inc. (4)
-
Phathom Pharmaceuticals, Inc. (2)
-
PLAYERS NETWORK (1)
-
Processa Pharmaceuticals, Inc. (3)
-
ProPhase Labs, Inc. (3)
-
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
-
QUANTA INC (3)
-
Recro Pharma, Inc. (1)
-
RespireRx Pharmaceuticals Inc. (14)
-
SCYNEXIS INC (2)
-
SenesTech, Inc. (1)
-
Target Group Inc. (1)
-
Tenzing Acquisition Corp. (8)
-
Terra Tech Corp. (16)
-
TETRAPHASE PHARMACEUTICALS INC (1)
-
Textmunication Holdings, Inc. (6)
-
Theravance Biopharma, Inc. (1)
-
United Cannabis Corp (2)
-
VIVUS INC (1)
-
Wize Pharma, Inc. (1)
-
XERIS PHARMACEUTICALS INC (1)
-
Zomedica Pharmaceuticals Corp. (1)
Recent Contracts
-
Convertible Note
(MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on June 15, 2021)
-
Form of Twelve-Month Note
(Terra Tech Corp., Filed With SEC on June 10, 2021)
-
Form of Six-Month Note
(Terra Tech Corp., Filed With SEC on June 10, 2021)
-
Form of February 2021 Convertible Note
(Wize Pharma, Inc., Filed With SEC on June 9, 2021)
-
Amendment No. 1 to 6% Subordinated Convertible Unsecured Promissory Note
(IntelGenx Technologies Corp., Filed With SEC on May 25, 2021)
-
Promissory Note of the Registrant, dated May 10, 2021 $386,400)
(Endexx Corp, Filed With SEC on May 24, 2021)
-
Promissory Note of the Registrant, dated May 10, 2021 ($250,000)
(Endexx Corp, Filed With SEC on May 24, 2021)
-
Amendment to 2020 ASOF Promissory Note
(Canbiola, Inc., Filed With SEC on May 21, 2021)
-
Amendment to 2020 ASOP Promissory Note
(Canbiola, Inc., Filed With SEC on May 21, 2021)
-
Form 2021 ASOF Original Issue Discount Senior Secured Convertible Promissory Note
(Canbiola, Inc., Filed With SEC on May 21, 2021)
